<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE LCTL_TEXT SYSTEM "ltf.v1.5.dtd">
<LCTL_TEXT lang="spa">
<DOC id="L0C04CVJW" lang="spa" tokenization="tokenization_parameters.v5.0" grammar="none" raw_text_char_length="3247" raw_text_md5="37e0253a511e8e5e71b15f1f11d8198d">
<TEXT>
<SEG id="segment-0" start_char="1" end_char="78">
<ORIGINAL_TEXT>El medicamento que reduce la mortalidad hasta un 71% en pacientes con COVID-19</ORIGINAL_TEXT>
<TOKEN id="token-0-0" pos="word" morph="none" start_char="1" end_char="2">El</TOKEN>
<TOKEN id="token-0-1" pos="word" morph="none" start_char="4" end_char="14">medicamento</TOKEN>
<TOKEN id="token-0-2" pos="word" morph="none" start_char="16" end_char="18">que</TOKEN>
<TOKEN id="token-0-3" pos="word" morph="none" start_char="20" end_char="25">reduce</TOKEN>
<TOKEN id="token-0-4" pos="word" morph="none" start_char="27" end_char="28">la</TOKEN>
<TOKEN id="token-0-5" pos="word" morph="none" start_char="30" end_char="39">mortalidad</TOKEN>
<TOKEN id="token-0-6" pos="word" morph="none" start_char="41" end_char="45">hasta</TOKEN>
<TOKEN id="token-0-7" pos="word" morph="none" start_char="47" end_char="48">un</TOKEN>
<TOKEN id="token-0-8" pos="word" morph="none" start_char="50" end_char="51">71</TOKEN>
<TOKEN id="token-0-9" pos="punct" morph="none" start_char="52" end_char="52">%</TOKEN>
<TOKEN id="token-0-10" pos="word" morph="none" start_char="54" end_char="55">en</TOKEN>
<TOKEN id="token-0-11" pos="word" morph="none" start_char="57" end_char="65">pacientes</TOKEN>
<TOKEN id="token-0-12" pos="word" morph="none" start_char="67" end_char="69">con</TOKEN>
<TOKEN id="token-0-13" pos="unknown" morph="none" start_char="71" end_char="78">COVID-19</TOKEN>
</SEG>
<SEG id="segment-1" start_char="82" end_char="88">
<ORIGINAL_TEXT>STR AFP</ORIGINAL_TEXT>
<TOKEN id="token-1-0" pos="word" morph="none" start_char="82" end_char="84">STR</TOKEN>
<TOKEN id="token-1-1" pos="word" morph="none" start_char="86" end_char="88">AFP</TOKEN>
</SEG>
<SEG id="segment-2" start_char="92" end_char="566">
<ORIGINAL_TEXT>El fármaco baricitinib, identificado gracias a una investigación previa basada en la inteligencia artificial, para la artritis reumatoide puede bloquear la entrada viral y reducir la mortalidad en pacientes con COVID-19 cuyo estado va de moderado a grave, según una investigación traslacional de un equipo internacional coordinado por expertos del Karolinska Institutet en Suecia y en el que han participado investigadores del Complejo Hospitalario Universitario de Albacete.</ORIGINAL_TEXT>
<TOKEN id="token-2-0" pos="word" morph="none" start_char="92" end_char="93">El</TOKEN>
<TOKEN id="token-2-1" pos="word" morph="none" start_char="95" end_char="101">fármaco</TOKEN>
<TOKEN id="token-2-2" pos="word" morph="none" start_char="103" end_char="113">baricitinib</TOKEN>
<TOKEN id="token-2-3" pos="punct" morph="none" start_char="114" end_char="114">,</TOKEN>
<TOKEN id="token-2-4" pos="word" morph="none" start_char="116" end_char="127">identificado</TOKEN>
<TOKEN id="token-2-5" pos="word" morph="none" start_char="129" end_char="135">gracias</TOKEN>
<TOKEN id="token-2-6" pos="word" morph="none" start_char="137" end_char="137">a</TOKEN>
<TOKEN id="token-2-7" pos="word" morph="none" start_char="139" end_char="141">una</TOKEN>
<TOKEN id="token-2-8" pos="word" morph="none" start_char="143" end_char="155">investigación</TOKEN>
<TOKEN id="token-2-9" pos="word" morph="none" start_char="157" end_char="162">previa</TOKEN>
<TOKEN id="token-2-10" pos="word" morph="none" start_char="164" end_char="169">basada</TOKEN>
<TOKEN id="token-2-11" pos="word" morph="none" start_char="171" end_char="172">en</TOKEN>
<TOKEN id="token-2-12" pos="word" morph="none" start_char="174" end_char="175">la</TOKEN>
<TOKEN id="token-2-13" pos="word" morph="none" start_char="177" end_char="188">inteligencia</TOKEN>
<TOKEN id="token-2-14" pos="word" morph="none" start_char="190" end_char="199">artificial</TOKEN>
<TOKEN id="token-2-15" pos="punct" morph="none" start_char="200" end_char="200">,</TOKEN>
<TOKEN id="token-2-16" pos="word" morph="none" start_char="202" end_char="205">para</TOKEN>
<TOKEN id="token-2-17" pos="word" morph="none" start_char="207" end_char="208">la</TOKEN>
<TOKEN id="token-2-18" pos="word" morph="none" start_char="210" end_char="217">artritis</TOKEN>
<TOKEN id="token-2-19" pos="word" morph="none" start_char="219" end_char="228">reumatoide</TOKEN>
<TOKEN id="token-2-20" pos="word" morph="none" start_char="230" end_char="234">puede</TOKEN>
<TOKEN id="token-2-21" pos="word" morph="none" start_char="236" end_char="243">bloquear</TOKEN>
<TOKEN id="token-2-22" pos="word" morph="none" start_char="245" end_char="246">la</TOKEN>
<TOKEN id="token-2-23" pos="word" morph="none" start_char="248" end_char="254">entrada</TOKEN>
<TOKEN id="token-2-24" pos="word" morph="none" start_char="256" end_char="260">viral</TOKEN>
<TOKEN id="token-2-25" pos="word" morph="none" start_char="262" end_char="262">y</TOKEN>
<TOKEN id="token-2-26" pos="word" morph="none" start_char="264" end_char="270">reducir</TOKEN>
<TOKEN id="token-2-27" pos="word" morph="none" start_char="272" end_char="273">la</TOKEN>
<TOKEN id="token-2-28" pos="word" morph="none" start_char="275" end_char="284">mortalidad</TOKEN>
<TOKEN id="token-2-29" pos="word" morph="none" start_char="286" end_char="287">en</TOKEN>
<TOKEN id="token-2-30" pos="word" morph="none" start_char="289" end_char="297">pacientes</TOKEN>
<TOKEN id="token-2-31" pos="word" morph="none" start_char="299" end_char="301">con</TOKEN>
<TOKEN id="token-2-32" pos="unknown" morph="none" start_char="303" end_char="310">COVID-19</TOKEN>
<TOKEN id="token-2-33" pos="word" morph="none" start_char="312" end_char="315">cuyo</TOKEN>
<TOKEN id="token-2-34" pos="word" morph="none" start_char="317" end_char="322">estado</TOKEN>
<TOKEN id="token-2-35" pos="word" morph="none" start_char="324" end_char="325">va</TOKEN>
<TOKEN id="token-2-36" pos="word" morph="none" start_char="327" end_char="328">de</TOKEN>
<TOKEN id="token-2-37" pos="word" morph="none" start_char="330" end_char="337">moderado</TOKEN>
<TOKEN id="token-2-38" pos="word" morph="none" start_char="339" end_char="339">a</TOKEN>
<TOKEN id="token-2-39" pos="word" morph="none" start_char="341" end_char="345">grave</TOKEN>
<TOKEN id="token-2-40" pos="punct" morph="none" start_char="346" end_char="346">,</TOKEN>
<TOKEN id="token-2-41" pos="word" morph="none" start_char="348" end_char="352">según</TOKEN>
<TOKEN id="token-2-42" pos="word" morph="none" start_char="354" end_char="356">una</TOKEN>
<TOKEN id="token-2-43" pos="word" morph="none" start_char="358" end_char="370">investigación</TOKEN>
<TOKEN id="token-2-44" pos="word" morph="none" start_char="372" end_char="383">traslacional</TOKEN>
<TOKEN id="token-2-45" pos="word" morph="none" start_char="385" end_char="386">de</TOKEN>
<TOKEN id="token-2-46" pos="word" morph="none" start_char="388" end_char="389">un</TOKEN>
<TOKEN id="token-2-47" pos="word" morph="none" start_char="391" end_char="396">equipo</TOKEN>
<TOKEN id="token-2-48" pos="word" morph="none" start_char="398" end_char="410">internacional</TOKEN>
<TOKEN id="token-2-49" pos="word" morph="none" start_char="412" end_char="421">coordinado</TOKEN>
<TOKEN id="token-2-50" pos="word" morph="none" start_char="423" end_char="425">por</TOKEN>
<TOKEN id="token-2-51" pos="word" morph="none" start_char="427" end_char="434">expertos</TOKEN>
<TOKEN id="token-2-52" pos="word" morph="none" start_char="436" end_char="438">del</TOKEN>
<TOKEN id="token-2-53" pos="word" morph="none" start_char="440" end_char="449">Karolinska</TOKEN>
<TOKEN id="token-2-54" pos="word" morph="none" start_char="451" end_char="460">Institutet</TOKEN>
<TOKEN id="token-2-55" pos="word" morph="none" start_char="462" end_char="463">en</TOKEN>
<TOKEN id="token-2-56" pos="word" morph="none" start_char="465" end_char="470">Suecia</TOKEN>
<TOKEN id="token-2-57" pos="word" morph="none" start_char="472" end_char="472">y</TOKEN>
<TOKEN id="token-2-58" pos="word" morph="none" start_char="474" end_char="475">en</TOKEN>
<TOKEN id="token-2-59" pos="word" morph="none" start_char="477" end_char="478">el</TOKEN>
<TOKEN id="token-2-60" pos="word" morph="none" start_char="480" end_char="482">que</TOKEN>
<TOKEN id="token-2-61" pos="word" morph="none" start_char="484" end_char="486">han</TOKEN>
<TOKEN id="token-2-62" pos="word" morph="none" start_char="488" end_char="498">participado</TOKEN>
<TOKEN id="token-2-63" pos="word" morph="none" start_char="500" end_char="513">investigadores</TOKEN>
<TOKEN id="token-2-64" pos="word" morph="none" start_char="515" end_char="517">del</TOKEN>
<TOKEN id="token-2-65" pos="word" morph="none" start_char="519" end_char="526">Complejo</TOKEN>
<TOKEN id="token-2-66" pos="word" morph="none" start_char="528" end_char="539">Hospitalario</TOKEN>
<TOKEN id="token-2-67" pos="word" morph="none" start_char="541" end_char="553">Universitario</TOKEN>
<TOKEN id="token-2-68" pos="word" morph="none" start_char="555" end_char="556">de</TOKEN>
<TOKEN id="token-2-69" pos="word" morph="none" start_char="558" end_char="565">Albacete</TOKEN>
<TOKEN id="token-2-70" pos="punct" morph="none" start_char="566" end_char="566">.</TOKEN>
</SEG>
<SEG id="segment-3" start_char="569" end_char="708">
<ORIGINAL_TEXT>"Nos complace informar de una reducción del 71 por ciento en la mortalidad del grupo que recibió baricitinib además de la atención estándar.</ORIGINAL_TEXT>
<TOKEN id="token-3-0" pos="punct" morph="none" start_char="569" end_char="569">"</TOKEN>
<TOKEN id="token-3-1" pos="word" morph="none" start_char="570" end_char="572">Nos</TOKEN>
<TOKEN id="token-3-2" pos="word" morph="none" start_char="574" end_char="581">complace</TOKEN>
<TOKEN id="token-3-3" pos="word" morph="none" start_char="583" end_char="590">informar</TOKEN>
<TOKEN id="token-3-4" pos="word" morph="none" start_char="592" end_char="593">de</TOKEN>
<TOKEN id="token-3-5" pos="word" morph="none" start_char="595" end_char="597">una</TOKEN>
<TOKEN id="token-3-6" pos="word" morph="none" start_char="599" end_char="607">reducción</TOKEN>
<TOKEN id="token-3-7" pos="word" morph="none" start_char="609" end_char="611">del</TOKEN>
<TOKEN id="token-3-8" pos="word" morph="none" start_char="613" end_char="614">71</TOKEN>
<TOKEN id="token-3-9" pos="word" morph="none" start_char="616" end_char="618">por</TOKEN>
<TOKEN id="token-3-10" pos="word" morph="none" start_char="620" end_char="625">ciento</TOKEN>
<TOKEN id="token-3-11" pos="word" morph="none" start_char="627" end_char="628">en</TOKEN>
<TOKEN id="token-3-12" pos="word" morph="none" start_char="630" end_char="631">la</TOKEN>
<TOKEN id="token-3-13" pos="word" morph="none" start_char="633" end_char="642">mortalidad</TOKEN>
<TOKEN id="token-3-14" pos="word" morph="none" start_char="644" end_char="646">del</TOKEN>
<TOKEN id="token-3-15" pos="word" morph="none" start_char="648" end_char="652">grupo</TOKEN>
<TOKEN id="token-3-16" pos="word" morph="none" start_char="654" end_char="656">que</TOKEN>
<TOKEN id="token-3-17" pos="word" morph="none" start_char="658" end_char="664">recibió</TOKEN>
<TOKEN id="token-3-18" pos="word" morph="none" start_char="666" end_char="676">baricitinib</TOKEN>
<TOKEN id="token-3-19" pos="word" morph="none" start_char="678" end_char="683">además</TOKEN>
<TOKEN id="token-3-20" pos="word" morph="none" start_char="685" end_char="686">de</TOKEN>
<TOKEN id="token-3-21" pos="word" morph="none" start_char="688" end_char="689">la</TOKEN>
<TOKEN id="token-3-22" pos="word" morph="none" start_char="691" end_char="698">atención</TOKEN>
<TOKEN id="token-3-23" pos="word" morph="none" start_char="700" end_char="707">estándar</TOKEN>
<TOKEN id="token-3-24" pos="punct" morph="none" start_char="708" end_char="708">.</TOKEN>
</SEG>
<SEG id="segment-4" start_char="710" end_char="1064">
<ORIGINAL_TEXT>Estos resultados son especialmente alentadores dado que el estudio incluyó una gran cohorte de pacientes ancianos, un grupo que a menudo se excluye en otros ensayos", explica Volker Lauschke, autor del trabajo y profesor asociado de medicina personalizada y desarrollo de fármacos en el Departamento de Fisiología y Farmacología del Karolinska Institutet.</ORIGINAL_TEXT>
<TOKEN id="token-4-0" pos="word" morph="none" start_char="710" end_char="714">Estos</TOKEN>
<TOKEN id="token-4-1" pos="word" morph="none" start_char="716" end_char="725">resultados</TOKEN>
<TOKEN id="token-4-2" pos="word" morph="none" start_char="727" end_char="729">son</TOKEN>
<TOKEN id="token-4-3" pos="word" morph="none" start_char="731" end_char="743">especialmente</TOKEN>
<TOKEN id="token-4-4" pos="word" morph="none" start_char="745" end_char="755">alentadores</TOKEN>
<TOKEN id="token-4-5" pos="word" morph="none" start_char="757" end_char="760">dado</TOKEN>
<TOKEN id="token-4-6" pos="word" morph="none" start_char="762" end_char="764">que</TOKEN>
<TOKEN id="token-4-7" pos="word" morph="none" start_char="766" end_char="767">el</TOKEN>
<TOKEN id="token-4-8" pos="word" morph="none" start_char="769" end_char="775">estudio</TOKEN>
<TOKEN id="token-4-9" pos="word" morph="none" start_char="777" end_char="783">incluyó</TOKEN>
<TOKEN id="token-4-10" pos="word" morph="none" start_char="785" end_char="787">una</TOKEN>
<TOKEN id="token-4-11" pos="word" morph="none" start_char="789" end_char="792">gran</TOKEN>
<TOKEN id="token-4-12" pos="word" morph="none" start_char="794" end_char="800">cohorte</TOKEN>
<TOKEN id="token-4-13" pos="word" morph="none" start_char="802" end_char="803">de</TOKEN>
<TOKEN id="token-4-14" pos="word" morph="none" start_char="805" end_char="813">pacientes</TOKEN>
<TOKEN id="token-4-15" pos="word" morph="none" start_char="815" end_char="822">ancianos</TOKEN>
<TOKEN id="token-4-16" pos="punct" morph="none" start_char="823" end_char="823">,</TOKEN>
<TOKEN id="token-4-17" pos="word" morph="none" start_char="825" end_char="826">un</TOKEN>
<TOKEN id="token-4-18" pos="word" morph="none" start_char="828" end_char="832">grupo</TOKEN>
<TOKEN id="token-4-19" pos="word" morph="none" start_char="834" end_char="836">que</TOKEN>
<TOKEN id="token-4-20" pos="word" morph="none" start_char="838" end_char="838">a</TOKEN>
<TOKEN id="token-4-21" pos="word" morph="none" start_char="840" end_char="845">menudo</TOKEN>
<TOKEN id="token-4-22" pos="word" morph="none" start_char="847" end_char="848">se</TOKEN>
<TOKEN id="token-4-23" pos="word" morph="none" start_char="850" end_char="856">excluye</TOKEN>
<TOKEN id="token-4-24" pos="word" morph="none" start_char="858" end_char="859">en</TOKEN>
<TOKEN id="token-4-25" pos="word" morph="none" start_char="861" end_char="865">otros</TOKEN>
<TOKEN id="token-4-26" pos="word" morph="none" start_char="867" end_char="873">ensayos</TOKEN>
<TOKEN id="token-4-27" pos="punct" morph="none" start_char="874" end_char="875">",</TOKEN>
<TOKEN id="token-4-28" pos="word" morph="none" start_char="877" end_char="883">explica</TOKEN>
<TOKEN id="token-4-29" pos="word" morph="none" start_char="885" end_char="890">Volker</TOKEN>
<TOKEN id="token-4-30" pos="word" morph="none" start_char="892" end_char="899">Lauschke</TOKEN>
<TOKEN id="token-4-31" pos="punct" morph="none" start_char="900" end_char="900">,</TOKEN>
<TOKEN id="token-4-32" pos="word" morph="none" start_char="902" end_char="906">autor</TOKEN>
<TOKEN id="token-4-33" pos="word" morph="none" start_char="908" end_char="910">del</TOKEN>
<TOKEN id="token-4-34" pos="word" morph="none" start_char="912" end_char="918">trabajo</TOKEN>
<TOKEN id="token-4-35" pos="word" morph="none" start_char="920" end_char="920">y</TOKEN>
<TOKEN id="token-4-36" pos="word" morph="none" start_char="922" end_char="929">profesor</TOKEN>
<TOKEN id="token-4-37" pos="word" morph="none" start_char="931" end_char="938">asociado</TOKEN>
<TOKEN id="token-4-38" pos="word" morph="none" start_char="940" end_char="941">de</TOKEN>
<TOKEN id="token-4-39" pos="word" morph="none" start_char="943" end_char="950">medicina</TOKEN>
<TOKEN id="token-4-40" pos="word" morph="none" start_char="952" end_char="964">personalizada</TOKEN>
<TOKEN id="token-4-41" pos="word" morph="none" start_char="966" end_char="966">y</TOKEN>
<TOKEN id="token-4-42" pos="word" morph="none" start_char="968" end_char="977">desarrollo</TOKEN>
<TOKEN id="token-4-43" pos="word" morph="none" start_char="979" end_char="980">de</TOKEN>
<TOKEN id="token-4-44" pos="word" morph="none" start_char="982" end_char="989">fármacos</TOKEN>
<TOKEN id="token-4-45" pos="word" morph="none" start_char="991" end_char="992">en</TOKEN>
<TOKEN id="token-4-46" pos="word" morph="none" start_char="994" end_char="995">el</TOKEN>
<TOKEN id="token-4-47" pos="word" morph="none" start_char="997" end_char="1008">Departamento</TOKEN>
<TOKEN id="token-4-48" pos="word" morph="none" start_char="1010" end_char="1011">de</TOKEN>
<TOKEN id="token-4-49" pos="word" morph="none" start_char="1013" end_char="1022">Fisiología</TOKEN>
<TOKEN id="token-4-50" pos="word" morph="none" start_char="1024" end_char="1024">y</TOKEN>
<TOKEN id="token-4-51" pos="word" morph="none" start_char="1026" end_char="1037">Farmacología</TOKEN>
<TOKEN id="token-4-52" pos="word" morph="none" start_char="1039" end_char="1041">del</TOKEN>
<TOKEN id="token-4-53" pos="word" morph="none" start_char="1043" end_char="1052">Karolinska</TOKEN>
<TOKEN id="token-4-54" pos="word" morph="none" start_char="1054" end_char="1063">Institutet</TOKEN>
<TOKEN id="token-4-55" pos="punct" morph="none" start_char="1064" end_char="1064">.</TOKEN>
</SEG>
<SEG id="segment-5" start_char="1067" end_char="1230">
<ORIGINAL_TEXT>En el estudio, 83 pacientes hospitalizados en Italia y España con neumonía provocada por la COVID-19 fueron tratados con baricitinib además de la atención estándar.</ORIGINAL_TEXT>
<TOKEN id="token-5-0" pos="word" morph="none" start_char="1067" end_char="1068">En</TOKEN>
<TOKEN id="token-5-1" pos="word" morph="none" start_char="1070" end_char="1071">el</TOKEN>
<TOKEN id="token-5-2" pos="word" morph="none" start_char="1073" end_char="1079">estudio</TOKEN>
<TOKEN id="token-5-3" pos="punct" morph="none" start_char="1080" end_char="1080">,</TOKEN>
<TOKEN id="token-5-4" pos="word" morph="none" start_char="1082" end_char="1083">83</TOKEN>
<TOKEN id="token-5-5" pos="word" morph="none" start_char="1085" end_char="1093">pacientes</TOKEN>
<TOKEN id="token-5-6" pos="word" morph="none" start_char="1095" end_char="1108">hospitalizados</TOKEN>
<TOKEN id="token-5-7" pos="word" morph="none" start_char="1110" end_char="1111">en</TOKEN>
<TOKEN id="token-5-8" pos="word" morph="none" start_char="1113" end_char="1118">Italia</TOKEN>
<TOKEN id="token-5-9" pos="word" morph="none" start_char="1120" end_char="1120">y</TOKEN>
<TOKEN id="token-5-10" pos="word" morph="none" start_char="1122" end_char="1127">España</TOKEN>
<TOKEN id="token-5-11" pos="word" morph="none" start_char="1129" end_char="1131">con</TOKEN>
<TOKEN id="token-5-12" pos="word" morph="none" start_char="1133" end_char="1140">neumonía</TOKEN>
<TOKEN id="token-5-13" pos="word" morph="none" start_char="1142" end_char="1150">provocada</TOKEN>
<TOKEN id="token-5-14" pos="word" morph="none" start_char="1152" end_char="1154">por</TOKEN>
<TOKEN id="token-5-15" pos="word" morph="none" start_char="1156" end_char="1157">la</TOKEN>
<TOKEN id="token-5-16" pos="unknown" morph="none" start_char="1159" end_char="1166">COVID-19</TOKEN>
<TOKEN id="token-5-17" pos="word" morph="none" start_char="1168" end_char="1173">fueron</TOKEN>
<TOKEN id="token-5-18" pos="word" morph="none" start_char="1175" end_char="1182">tratados</TOKEN>
<TOKEN id="token-5-19" pos="word" morph="none" start_char="1184" end_char="1186">con</TOKEN>
<TOKEN id="token-5-20" pos="word" morph="none" start_char="1188" end_char="1198">baricitinib</TOKEN>
<TOKEN id="token-5-21" pos="word" morph="none" start_char="1200" end_char="1205">además</TOKEN>
<TOKEN id="token-5-22" pos="word" morph="none" start_char="1207" end_char="1208">de</TOKEN>
<TOKEN id="token-5-23" pos="word" morph="none" start_char="1210" end_char="1211">la</TOKEN>
<TOKEN id="token-5-24" pos="word" morph="none" start_char="1213" end_char="1220">atención</TOKEN>
<TOKEN id="token-5-25" pos="word" morph="none" start_char="1222" end_char="1229">estándar</TOKEN>
<TOKEN id="token-5-26" pos="punct" morph="none" start_char="1230" end_char="1230">.</TOKEN>
</SEG>
<SEG id="segment-6" start_char="1232" end_char="1343">
<ORIGINAL_TEXT>De estos, el 17 por ciento sufrió un resultado adverso que resultó en la muerte o ventilación mecánica invasiva.</ORIGINAL_TEXT>
<TOKEN id="token-6-0" pos="word" morph="none" start_char="1232" end_char="1233">De</TOKEN>
<TOKEN id="token-6-1" pos="word" morph="none" start_char="1235" end_char="1239">estos</TOKEN>
<TOKEN id="token-6-2" pos="punct" morph="none" start_char="1240" end_char="1240">,</TOKEN>
<TOKEN id="token-6-3" pos="word" morph="none" start_char="1242" end_char="1243">el</TOKEN>
<TOKEN id="token-6-4" pos="word" morph="none" start_char="1245" end_char="1246">17</TOKEN>
<TOKEN id="token-6-5" pos="word" morph="none" start_char="1248" end_char="1250">por</TOKEN>
<TOKEN id="token-6-6" pos="word" morph="none" start_char="1252" end_char="1257">ciento</TOKEN>
<TOKEN id="token-6-7" pos="word" morph="none" start_char="1259" end_char="1264">sufrió</TOKEN>
<TOKEN id="token-6-8" pos="word" morph="none" start_char="1266" end_char="1267">un</TOKEN>
<TOKEN id="token-6-9" pos="word" morph="none" start_char="1269" end_char="1277">resultado</TOKEN>
<TOKEN id="token-6-10" pos="word" morph="none" start_char="1279" end_char="1285">adverso</TOKEN>
<TOKEN id="token-6-11" pos="word" morph="none" start_char="1287" end_char="1289">que</TOKEN>
<TOKEN id="token-6-12" pos="word" morph="none" start_char="1291" end_char="1297">resultó</TOKEN>
<TOKEN id="token-6-13" pos="word" morph="none" start_char="1299" end_char="1300">en</TOKEN>
<TOKEN id="token-6-14" pos="word" morph="none" start_char="1302" end_char="1303">la</TOKEN>
<TOKEN id="token-6-15" pos="word" morph="none" start_char="1305" end_char="1310">muerte</TOKEN>
<TOKEN id="token-6-16" pos="word" morph="none" start_char="1312" end_char="1312">o</TOKEN>
<TOKEN id="token-6-17" pos="word" morph="none" start_char="1314" end_char="1324">ventilación</TOKEN>
<TOKEN id="token-6-18" pos="word" morph="none" start_char="1326" end_char="1333">mecánica</TOKEN>
<TOKEN id="token-6-19" pos="word" morph="none" start_char="1335" end_char="1342">invasiva</TOKEN>
<TOKEN id="token-6-20" pos="punct" morph="none" start_char="1343" end_char="1343">.</TOKEN>
</SEG>
<SEG id="segment-7" start_char="1345" end_char="1469">
<ORIGINAL_TEXT>Esto se compara con el 35 por ciento en el grupo de control emparejado de 83 pacientes que solo recibieron atención estándar.</ORIGINAL_TEXT>
<TOKEN id="token-7-0" pos="word" morph="none" start_char="1345" end_char="1348">Esto</TOKEN>
<TOKEN id="token-7-1" pos="word" morph="none" start_char="1350" end_char="1351">se</TOKEN>
<TOKEN id="token-7-2" pos="word" morph="none" start_char="1353" end_char="1359">compara</TOKEN>
<TOKEN id="token-7-3" pos="word" morph="none" start_char="1361" end_char="1363">con</TOKEN>
<TOKEN id="token-7-4" pos="word" morph="none" start_char="1365" end_char="1366">el</TOKEN>
<TOKEN id="token-7-5" pos="word" morph="none" start_char="1368" end_char="1369">35</TOKEN>
<TOKEN id="token-7-6" pos="word" morph="none" start_char="1371" end_char="1373">por</TOKEN>
<TOKEN id="token-7-7" pos="word" morph="none" start_char="1375" end_char="1380">ciento</TOKEN>
<TOKEN id="token-7-8" pos="word" morph="none" start_char="1382" end_char="1383">en</TOKEN>
<TOKEN id="token-7-9" pos="word" morph="none" start_char="1385" end_char="1386">el</TOKEN>
<TOKEN id="token-7-10" pos="word" morph="none" start_char="1388" end_char="1392">grupo</TOKEN>
<TOKEN id="token-7-11" pos="word" morph="none" start_char="1394" end_char="1395">de</TOKEN>
<TOKEN id="token-7-12" pos="word" morph="none" start_char="1397" end_char="1403">control</TOKEN>
<TOKEN id="token-7-13" pos="word" morph="none" start_char="1405" end_char="1414">emparejado</TOKEN>
<TOKEN id="token-7-14" pos="word" morph="none" start_char="1416" end_char="1417">de</TOKEN>
<TOKEN id="token-7-15" pos="word" morph="none" start_char="1419" end_char="1420">83</TOKEN>
<TOKEN id="token-7-16" pos="word" morph="none" start_char="1422" end_char="1430">pacientes</TOKEN>
<TOKEN id="token-7-17" pos="word" morph="none" start_char="1432" end_char="1434">que</TOKEN>
<TOKEN id="token-7-18" pos="word" morph="none" start_char="1436" end_char="1439">solo</TOKEN>
<TOKEN id="token-7-19" pos="word" morph="none" start_char="1441" end_char="1450">recibieron</TOKEN>
<TOKEN id="token-7-20" pos="word" morph="none" start_char="1452" end_char="1459">atención</TOKEN>
<TOKEN id="token-7-21" pos="word" morph="none" start_char="1461" end_char="1468">estándar</TOKEN>
<TOKEN id="token-7-22" pos="punct" morph="none" start_char="1469" end_char="1469">.</TOKEN>
</SEG>
<SEG id="segment-8" start_char="1472" end_char="1497">
<ORIGINAL_TEXT>Datos sobre el baricitinib</ORIGINAL_TEXT>
<TOKEN id="token-8-0" pos="word" morph="none" start_char="1472" end_char="1476">Datos</TOKEN>
<TOKEN id="token-8-1" pos="word" morph="none" start_char="1478" end_char="1482">sobre</TOKEN>
<TOKEN id="token-8-2" pos="word" morph="none" start_char="1484" end_char="1485">el</TOKEN>
<TOKEN id="token-8-3" pos="word" morph="none" start_char="1487" end_char="1497">baricitinib</TOKEN>
</SEG>
<SEG id="segment-9" start_char="1502" end_char="1656">
<ORIGINAL_TEXT>El baricitinib es un fármaco oral que se toma una vez al día y se usa para el tratamiento de pacientes adultos con artritis reumatoide de moderada a grave.</ORIGINAL_TEXT>
<TOKEN id="token-9-0" pos="word" morph="none" start_char="1502" end_char="1503">El</TOKEN>
<TOKEN id="token-9-1" pos="word" morph="none" start_char="1505" end_char="1515">baricitinib</TOKEN>
<TOKEN id="token-9-2" pos="word" morph="none" start_char="1517" end_char="1518">es</TOKEN>
<TOKEN id="token-9-3" pos="word" morph="none" start_char="1520" end_char="1521">un</TOKEN>
<TOKEN id="token-9-4" pos="word" morph="none" start_char="1523" end_char="1529">fármaco</TOKEN>
<TOKEN id="token-9-5" pos="word" morph="none" start_char="1531" end_char="1534">oral</TOKEN>
<TOKEN id="token-9-6" pos="word" morph="none" start_char="1536" end_char="1538">que</TOKEN>
<TOKEN id="token-9-7" pos="word" morph="none" start_char="1540" end_char="1541">se</TOKEN>
<TOKEN id="token-9-8" pos="word" morph="none" start_char="1543" end_char="1546">toma</TOKEN>
<TOKEN id="token-9-9" pos="word" morph="none" start_char="1548" end_char="1550">una</TOKEN>
<TOKEN id="token-9-10" pos="word" morph="none" start_char="1552" end_char="1554">vez</TOKEN>
<TOKEN id="token-9-11" pos="word" morph="none" start_char="1556" end_char="1557">al</TOKEN>
<TOKEN id="token-9-12" pos="word" morph="none" start_char="1559" end_char="1561">día</TOKEN>
<TOKEN id="token-9-13" pos="word" morph="none" start_char="1563" end_char="1563">y</TOKEN>
<TOKEN id="token-9-14" pos="word" morph="none" start_char="1565" end_char="1566">se</TOKEN>
<TOKEN id="token-9-15" pos="word" morph="none" start_char="1568" end_char="1570">usa</TOKEN>
<TOKEN id="token-9-16" pos="word" morph="none" start_char="1572" end_char="1575">para</TOKEN>
<TOKEN id="token-9-17" pos="word" morph="none" start_char="1577" end_char="1578">el</TOKEN>
<TOKEN id="token-9-18" pos="word" morph="none" start_char="1580" end_char="1590">tratamiento</TOKEN>
<TOKEN id="token-9-19" pos="word" morph="none" start_char="1592" end_char="1593">de</TOKEN>
<TOKEN id="token-9-20" pos="word" morph="none" start_char="1595" end_char="1603">pacientes</TOKEN>
<TOKEN id="token-9-21" pos="word" morph="none" start_char="1605" end_char="1611">adultos</TOKEN>
<TOKEN id="token-9-22" pos="word" morph="none" start_char="1613" end_char="1615">con</TOKEN>
<TOKEN id="token-9-23" pos="word" morph="none" start_char="1617" end_char="1624">artritis</TOKEN>
<TOKEN id="token-9-24" pos="word" morph="none" start_char="1626" end_char="1635">reumatoide</TOKEN>
<TOKEN id="token-9-25" pos="word" morph="none" start_char="1637" end_char="1638">de</TOKEN>
<TOKEN id="token-9-26" pos="word" morph="none" start_char="1640" end_char="1647">moderada</TOKEN>
<TOKEN id="token-9-27" pos="word" morph="none" start_char="1649" end_char="1649">a</TOKEN>
<TOKEN id="token-9-28" pos="word" morph="none" start_char="1651" end_char="1655">grave</TOKEN>
<TOKEN id="token-9-29" pos="punct" morph="none" start_char="1656" end_char="1656">.</TOKEN>
</SEG>
<SEG id="segment-10" start_char="1660" end_char="1809">
<ORIGINAL_TEXT>Actúa como un inhibidor de la janus quinasa, un tipo de enzima que actúa como un interruptor de ‘encendido’ o ‘apagado’ en muchas funciones celulares.</ORIGINAL_TEXT>
<TOKEN id="token-10-0" pos="word" morph="none" start_char="1660" end_char="1664">Actúa</TOKEN>
<TOKEN id="token-10-1" pos="word" morph="none" start_char="1666" end_char="1669">como</TOKEN>
<TOKEN id="token-10-2" pos="word" morph="none" start_char="1671" end_char="1672">un</TOKEN>
<TOKEN id="token-10-3" pos="word" morph="none" start_char="1674" end_char="1682">inhibidor</TOKEN>
<TOKEN id="token-10-4" pos="word" morph="none" start_char="1684" end_char="1685">de</TOKEN>
<TOKEN id="token-10-5" pos="word" morph="none" start_char="1687" end_char="1688">la</TOKEN>
<TOKEN id="token-10-6" pos="word" morph="none" start_char="1690" end_char="1694">janus</TOKEN>
<TOKEN id="token-10-7" pos="word" morph="none" start_char="1696" end_char="1702">quinasa</TOKEN>
<TOKEN id="token-10-8" pos="punct" morph="none" start_char="1703" end_char="1703">,</TOKEN>
<TOKEN id="token-10-9" pos="word" morph="none" start_char="1705" end_char="1706">un</TOKEN>
<TOKEN id="token-10-10" pos="word" morph="none" start_char="1708" end_char="1711">tipo</TOKEN>
<TOKEN id="token-10-11" pos="word" morph="none" start_char="1713" end_char="1714">de</TOKEN>
<TOKEN id="token-10-12" pos="word" morph="none" start_char="1716" end_char="1721">enzima</TOKEN>
<TOKEN id="token-10-13" pos="word" morph="none" start_char="1723" end_char="1725">que</TOKEN>
<TOKEN id="token-10-14" pos="word" morph="none" start_char="1727" end_char="1731">actúa</TOKEN>
<TOKEN id="token-10-15" pos="word" morph="none" start_char="1733" end_char="1736">como</TOKEN>
<TOKEN id="token-10-16" pos="word" morph="none" start_char="1738" end_char="1739">un</TOKEN>
<TOKEN id="token-10-17" pos="word" morph="none" start_char="1741" end_char="1751">interruptor</TOKEN>
<TOKEN id="token-10-18" pos="word" morph="none" start_char="1753" end_char="1754">de</TOKEN>
<TOKEN id="token-10-19" pos="punct" morph="none" start_char="1756" end_char="1756">‘</TOKEN>
<TOKEN id="token-10-20" pos="word" morph="none" start_char="1757" end_char="1765">encendido</TOKEN>
<TOKEN id="token-10-21" pos="punct" morph="none" start_char="1766" end_char="1766">’</TOKEN>
<TOKEN id="token-10-22" pos="word" morph="none" start_char="1768" end_char="1768">o</TOKEN>
<TOKEN id="token-10-23" pos="punct" morph="none" start_char="1770" end_char="1770">‘</TOKEN>
<TOKEN id="token-10-24" pos="word" morph="none" start_char="1771" end_char="1777">apagado</TOKEN>
<TOKEN id="token-10-25" pos="punct" morph="none" start_char="1778" end_char="1778">’</TOKEN>
<TOKEN id="token-10-26" pos="word" morph="none" start_char="1780" end_char="1781">en</TOKEN>
<TOKEN id="token-10-27" pos="word" morph="none" start_char="1783" end_char="1788">muchas</TOKEN>
<TOKEN id="token-10-28" pos="word" morph="none" start_char="1790" end_char="1798">funciones</TOKEN>
<TOKEN id="token-10-29" pos="word" morph="none" start_char="1800" end_char="1808">celulares</TOKEN>
<TOKEN id="token-10-30" pos="punct" morph="none" start_char="1809" end_char="1809">.</TOKEN>
</SEG>
<SEG id="segment-11" start_char="1813" end_char="1974">
<ORIGINAL_TEXT>El fármaco tiene una función dual y actúa interfiriendo con los procesos inflamatorios del sistema inmunitario, así como inhibiendo directamente la entrada viral.</ORIGINAL_TEXT>
<TOKEN id="token-11-0" pos="word" morph="none" start_char="1813" end_char="1814">El</TOKEN>
<TOKEN id="token-11-1" pos="word" morph="none" start_char="1816" end_char="1822">fármaco</TOKEN>
<TOKEN id="token-11-2" pos="word" morph="none" start_char="1824" end_char="1828">tiene</TOKEN>
<TOKEN id="token-11-3" pos="word" morph="none" start_char="1830" end_char="1832">una</TOKEN>
<TOKEN id="token-11-4" pos="word" morph="none" start_char="1834" end_char="1840">función</TOKEN>
<TOKEN id="token-11-5" pos="word" morph="none" start_char="1842" end_char="1845">dual</TOKEN>
<TOKEN id="token-11-6" pos="word" morph="none" start_char="1847" end_char="1847">y</TOKEN>
<TOKEN id="token-11-7" pos="word" morph="none" start_char="1849" end_char="1853">actúa</TOKEN>
<TOKEN id="token-11-8" pos="word" morph="none" start_char="1855" end_char="1867">interfiriendo</TOKEN>
<TOKEN id="token-11-9" pos="word" morph="none" start_char="1869" end_char="1871">con</TOKEN>
<TOKEN id="token-11-10" pos="word" morph="none" start_char="1873" end_char="1875">los</TOKEN>
<TOKEN id="token-11-11" pos="word" morph="none" start_char="1877" end_char="1884">procesos</TOKEN>
<TOKEN id="token-11-12" pos="word" morph="none" start_char="1886" end_char="1898">inflamatorios</TOKEN>
<TOKEN id="token-11-13" pos="word" morph="none" start_char="1900" end_char="1902">del</TOKEN>
<TOKEN id="token-11-14" pos="word" morph="none" start_char="1904" end_char="1910">sistema</TOKEN>
<TOKEN id="token-11-15" pos="word" morph="none" start_char="1912" end_char="1922">inmunitario</TOKEN>
<TOKEN id="token-11-16" pos="punct" morph="none" start_char="1923" end_char="1923">,</TOKEN>
<TOKEN id="token-11-17" pos="word" morph="none" start_char="1925" end_char="1927">así</TOKEN>
<TOKEN id="token-11-18" pos="word" morph="none" start_char="1929" end_char="1932">como</TOKEN>
<TOKEN id="token-11-19" pos="word" morph="none" start_char="1934" end_char="1943">inhibiendo</TOKEN>
<TOKEN id="token-11-20" pos="word" morph="none" start_char="1945" end_char="1956">directamente</TOKEN>
<TOKEN id="token-11-21" pos="word" morph="none" start_char="1958" end_char="1959">la</TOKEN>
<TOKEN id="token-11-22" pos="word" morph="none" start_char="1961" end_char="1967">entrada</TOKEN>
<TOKEN id="token-11-23" pos="word" morph="none" start_char="1969" end_char="1973">viral</TOKEN>
<TOKEN id="token-11-24" pos="punct" morph="none" start_char="1974" end_char="1974">.</TOKEN>
</SEG>
<SEG id="segment-12" start_char="1978" end_char="2039">
<ORIGINAL_TEXT>Se considera un posible candidato a tratamiento para COVID-19.</ORIGINAL_TEXT>
<TOKEN id="token-12-0" pos="word" morph="none" start_char="1978" end_char="1979">Se</TOKEN>
<TOKEN id="token-12-1" pos="word" morph="none" start_char="1981" end_char="1989">considera</TOKEN>
<TOKEN id="token-12-2" pos="word" morph="none" start_char="1991" end_char="1992">un</TOKEN>
<TOKEN id="token-12-3" pos="word" morph="none" start_char="1994" end_char="2000">posible</TOKEN>
<TOKEN id="token-12-4" pos="word" morph="none" start_char="2002" end_char="2010">candidato</TOKEN>
<TOKEN id="token-12-5" pos="word" morph="none" start_char="2012" end_char="2012">a</TOKEN>
<TOKEN id="token-12-6" pos="word" morph="none" start_char="2014" end_char="2024">tratamiento</TOKEN>
<TOKEN id="token-12-7" pos="word" morph="none" start_char="2026" end_char="2029">para</TOKEN>
<TOKEN id="token-12-8" pos="unknown" morph="none" start_char="2031" end_char="2038">COVID-19</TOKEN>
<TOKEN id="token-12-9" pos="punct" morph="none" start_char="2039" end_char="2039">.</TOKEN>
</SEG>
<SEG id="segment-13" start_char="2044" end_char="2275">
<ORIGINAL_TEXT>En la investigación, publicada en la revista ‘Science Advances’, los científicos cultivaron órganos humanos en miniatura en el laboratorio, llamados organoides, para investigar cómo exactamente el fármaco puede combatir el COVID-19.</ORIGINAL_TEXT>
<TOKEN id="token-13-0" pos="word" morph="none" start_char="2044" end_char="2045">En</TOKEN>
<TOKEN id="token-13-1" pos="word" morph="none" start_char="2047" end_char="2048">la</TOKEN>
<TOKEN id="token-13-2" pos="word" morph="none" start_char="2050" end_char="2062">investigación</TOKEN>
<TOKEN id="token-13-3" pos="punct" morph="none" start_char="2063" end_char="2063">,</TOKEN>
<TOKEN id="token-13-4" pos="word" morph="none" start_char="2065" end_char="2073">publicada</TOKEN>
<TOKEN id="token-13-5" pos="word" morph="none" start_char="2075" end_char="2076">en</TOKEN>
<TOKEN id="token-13-6" pos="word" morph="none" start_char="2078" end_char="2079">la</TOKEN>
<TOKEN id="token-13-7" pos="word" morph="none" start_char="2081" end_char="2087">revista</TOKEN>
<TOKEN id="token-13-8" pos="punct" morph="none" start_char="2089" end_char="2089">‘</TOKEN>
<TOKEN id="token-13-9" pos="word" morph="none" start_char="2090" end_char="2096">Science</TOKEN>
<TOKEN id="token-13-10" pos="word" morph="none" start_char="2098" end_char="2105">Advances</TOKEN>
<TOKEN id="token-13-11" pos="punct" morph="none" start_char="2106" end_char="2107">’,</TOKEN>
<TOKEN id="token-13-12" pos="word" morph="none" start_char="2109" end_char="2111">los</TOKEN>
<TOKEN id="token-13-13" pos="word" morph="none" start_char="2113" end_char="2123">científicos</TOKEN>
<TOKEN id="token-13-14" pos="word" morph="none" start_char="2125" end_char="2134">cultivaron</TOKEN>
<TOKEN id="token-13-15" pos="word" morph="none" start_char="2136" end_char="2142">órganos</TOKEN>
<TOKEN id="token-13-16" pos="word" morph="none" start_char="2144" end_char="2150">humanos</TOKEN>
<TOKEN id="token-13-17" pos="word" morph="none" start_char="2152" end_char="2153">en</TOKEN>
<TOKEN id="token-13-18" pos="word" morph="none" start_char="2155" end_char="2163">miniatura</TOKEN>
<TOKEN id="token-13-19" pos="word" morph="none" start_char="2165" end_char="2166">en</TOKEN>
<TOKEN id="token-13-20" pos="word" morph="none" start_char="2168" end_char="2169">el</TOKEN>
<TOKEN id="token-13-21" pos="word" morph="none" start_char="2171" end_char="2181">laboratorio</TOKEN>
<TOKEN id="token-13-22" pos="punct" morph="none" start_char="2182" end_char="2182">,</TOKEN>
<TOKEN id="token-13-23" pos="word" morph="none" start_char="2184" end_char="2191">llamados</TOKEN>
<TOKEN id="token-13-24" pos="word" morph="none" start_char="2193" end_char="2202">organoides</TOKEN>
<TOKEN id="token-13-25" pos="punct" morph="none" start_char="2203" end_char="2203">,</TOKEN>
<TOKEN id="token-13-26" pos="word" morph="none" start_char="2205" end_char="2208">para</TOKEN>
<TOKEN id="token-13-27" pos="word" morph="none" start_char="2210" end_char="2219">investigar</TOKEN>
<TOKEN id="token-13-28" pos="word" morph="none" start_char="2221" end_char="2224">cómo</TOKEN>
<TOKEN id="token-13-29" pos="word" morph="none" start_char="2226" end_char="2236">exactamente</TOKEN>
<TOKEN id="token-13-30" pos="word" morph="none" start_char="2238" end_char="2239">el</TOKEN>
<TOKEN id="token-13-31" pos="word" morph="none" start_char="2241" end_char="2247">fármaco</TOKEN>
<TOKEN id="token-13-32" pos="word" morph="none" start_char="2249" end_char="2253">puede</TOKEN>
<TOKEN id="token-13-33" pos="word" morph="none" start_char="2255" end_char="2262">combatir</TOKEN>
<TOKEN id="token-13-34" pos="word" morph="none" start_char="2264" end_char="2265">el</TOKEN>
<TOKEN id="token-13-35" pos="unknown" morph="none" start_char="2267" end_char="2274">COVID-19</TOKEN>
<TOKEN id="token-13-36" pos="punct" morph="none" start_char="2275" end_char="2275">.</TOKEN>
</SEG>
<SEG id="segment-14" start_char="2277" end_char="2489">
<ORIGINAL_TEXT>Los hallazgos revelaron que el medicamento en cuestión puede ayudar a trabajar de dos maneras: reduciendo el daño a los órganos causado por la inflamación, y bloqueando la entrada del virus en las células humanas.</ORIGINAL_TEXT>
<TOKEN id="token-14-0" pos="word" morph="none" start_char="2277" end_char="2279">Los</TOKEN>
<TOKEN id="token-14-1" pos="word" morph="none" start_char="2281" end_char="2289">hallazgos</TOKEN>
<TOKEN id="token-14-2" pos="word" morph="none" start_char="2291" end_char="2299">revelaron</TOKEN>
<TOKEN id="token-14-3" pos="word" morph="none" start_char="2301" end_char="2303">que</TOKEN>
<TOKEN id="token-14-4" pos="word" morph="none" start_char="2305" end_char="2306">el</TOKEN>
<TOKEN id="token-14-5" pos="word" morph="none" start_char="2308" end_char="2318">medicamento</TOKEN>
<TOKEN id="token-14-6" pos="word" morph="none" start_char="2320" end_char="2321">en</TOKEN>
<TOKEN id="token-14-7" pos="word" morph="none" start_char="2323" end_char="2330">cuestión</TOKEN>
<TOKEN id="token-14-8" pos="word" morph="none" start_char="2332" end_char="2336">puede</TOKEN>
<TOKEN id="token-14-9" pos="word" morph="none" start_char="2338" end_char="2343">ayudar</TOKEN>
<TOKEN id="token-14-10" pos="word" morph="none" start_char="2345" end_char="2345">a</TOKEN>
<TOKEN id="token-14-11" pos="word" morph="none" start_char="2347" end_char="2354">trabajar</TOKEN>
<TOKEN id="token-14-12" pos="word" morph="none" start_char="2356" end_char="2357">de</TOKEN>
<TOKEN id="token-14-13" pos="word" morph="none" start_char="2359" end_char="2361">dos</TOKEN>
<TOKEN id="token-14-14" pos="word" morph="none" start_char="2363" end_char="2369">maneras</TOKEN>
<TOKEN id="token-14-15" pos="punct" morph="none" start_char="2370" end_char="2370">:</TOKEN>
<TOKEN id="token-14-16" pos="word" morph="none" start_char="2372" end_char="2381">reduciendo</TOKEN>
<TOKEN id="token-14-17" pos="word" morph="none" start_char="2383" end_char="2384">el</TOKEN>
<TOKEN id="token-14-18" pos="word" morph="none" start_char="2386" end_char="2389">daño</TOKEN>
<TOKEN id="token-14-19" pos="word" morph="none" start_char="2391" end_char="2391">a</TOKEN>
<TOKEN id="token-14-20" pos="word" morph="none" start_char="2393" end_char="2395">los</TOKEN>
<TOKEN id="token-14-21" pos="word" morph="none" start_char="2397" end_char="2403">órganos</TOKEN>
<TOKEN id="token-14-22" pos="word" morph="none" start_char="2405" end_char="2411">causado</TOKEN>
<TOKEN id="token-14-23" pos="word" morph="none" start_char="2413" end_char="2415">por</TOKEN>
<TOKEN id="token-14-24" pos="word" morph="none" start_char="2417" end_char="2418">la</TOKEN>
<TOKEN id="token-14-25" pos="word" morph="none" start_char="2420" end_char="2430">inflamación</TOKEN>
<TOKEN id="token-14-26" pos="punct" morph="none" start_char="2431" end_char="2431">,</TOKEN>
<TOKEN id="token-14-27" pos="word" morph="none" start_char="2433" end_char="2433">y</TOKEN>
<TOKEN id="token-14-28" pos="word" morph="none" start_char="2435" end_char="2444">bloqueando</TOKEN>
<TOKEN id="token-14-29" pos="word" morph="none" start_char="2446" end_char="2447">la</TOKEN>
<TOKEN id="token-14-30" pos="word" morph="none" start_char="2449" end_char="2455">entrada</TOKEN>
<TOKEN id="token-14-31" pos="word" morph="none" start_char="2457" end_char="2459">del</TOKEN>
<TOKEN id="token-14-32" pos="word" morph="none" start_char="2461" end_char="2465">virus</TOKEN>
<TOKEN id="token-14-33" pos="word" morph="none" start_char="2467" end_char="2468">en</TOKEN>
<TOKEN id="token-14-34" pos="word" morph="none" start_char="2470" end_char="2472">las</TOKEN>
<TOKEN id="token-14-35" pos="word" morph="none" start_char="2474" end_char="2480">células</TOKEN>
<TOKEN id="token-14-36" pos="word" morph="none" start_char="2482" end_char="2488">humanas</TOKEN>
<TOKEN id="token-14-37" pos="punct" morph="none" start_char="2489" end_char="2489">.</TOKEN>
</SEG>
<SEG id="segment-15" start_char="2492" end_char="2787">
<ORIGINAL_TEXT>"Nuestros hallazgos explican las acciones duales anti-citocinas y anti-virales del baricitinib y respaldan una evaluación adicional en ensayos de control aleatorios", añade Ali Mirazimi, profesor adjunto del Departamento de Medicina de Laboratorio del Karolinska Institutet y coautor del estudio.</ORIGINAL_TEXT>
<TOKEN id="token-15-0" pos="punct" morph="none" start_char="2492" end_char="2492">"</TOKEN>
<TOKEN id="token-15-1" pos="word" morph="none" start_char="2493" end_char="2500">Nuestros</TOKEN>
<TOKEN id="token-15-2" pos="word" morph="none" start_char="2502" end_char="2510">hallazgos</TOKEN>
<TOKEN id="token-15-3" pos="word" morph="none" start_char="2512" end_char="2519">explican</TOKEN>
<TOKEN id="token-15-4" pos="word" morph="none" start_char="2521" end_char="2523">las</TOKEN>
<TOKEN id="token-15-5" pos="word" morph="none" start_char="2525" end_char="2532">acciones</TOKEN>
<TOKEN id="token-15-6" pos="word" morph="none" start_char="2534" end_char="2539">duales</TOKEN>
<TOKEN id="token-15-7" pos="unknown" morph="none" start_char="2541" end_char="2554">anti-citocinas</TOKEN>
<TOKEN id="token-15-8" pos="word" morph="none" start_char="2556" end_char="2556">y</TOKEN>
<TOKEN id="token-15-9" pos="unknown" morph="none" start_char="2558" end_char="2569">anti-virales</TOKEN>
<TOKEN id="token-15-10" pos="word" morph="none" start_char="2571" end_char="2573">del</TOKEN>
<TOKEN id="token-15-11" pos="word" morph="none" start_char="2575" end_char="2585">baricitinib</TOKEN>
<TOKEN id="token-15-12" pos="word" morph="none" start_char="2587" end_char="2587">y</TOKEN>
<TOKEN id="token-15-13" pos="word" morph="none" start_char="2589" end_char="2597">respaldan</TOKEN>
<TOKEN id="token-15-14" pos="word" morph="none" start_char="2599" end_char="2601">una</TOKEN>
<TOKEN id="token-15-15" pos="word" morph="none" start_char="2603" end_char="2612">evaluación</TOKEN>
<TOKEN id="token-15-16" pos="word" morph="none" start_char="2614" end_char="2622">adicional</TOKEN>
<TOKEN id="token-15-17" pos="word" morph="none" start_char="2624" end_char="2625">en</TOKEN>
<TOKEN id="token-15-18" pos="word" morph="none" start_char="2627" end_char="2633">ensayos</TOKEN>
<TOKEN id="token-15-19" pos="word" morph="none" start_char="2635" end_char="2636">de</TOKEN>
<TOKEN id="token-15-20" pos="word" morph="none" start_char="2638" end_char="2644">control</TOKEN>
<TOKEN id="token-15-21" pos="word" morph="none" start_char="2646" end_char="2655">aleatorios</TOKEN>
<TOKEN id="token-15-22" pos="punct" morph="none" start_char="2656" end_char="2657">",</TOKEN>
<TOKEN id="token-15-23" pos="word" morph="none" start_char="2659" end_char="2663">añade</TOKEN>
<TOKEN id="token-15-24" pos="word" morph="none" start_char="2665" end_char="2667">Ali</TOKEN>
<TOKEN id="token-15-25" pos="word" morph="none" start_char="2669" end_char="2676">Mirazimi</TOKEN>
<TOKEN id="token-15-26" pos="punct" morph="none" start_char="2677" end_char="2677">,</TOKEN>
<TOKEN id="token-15-27" pos="word" morph="none" start_char="2679" end_char="2686">profesor</TOKEN>
<TOKEN id="token-15-28" pos="word" morph="none" start_char="2688" end_char="2694">adjunto</TOKEN>
<TOKEN id="token-15-29" pos="word" morph="none" start_char="2696" end_char="2698">del</TOKEN>
<TOKEN id="token-15-30" pos="word" morph="none" start_char="2700" end_char="2711">Departamento</TOKEN>
<TOKEN id="token-15-31" pos="word" morph="none" start_char="2713" end_char="2714">de</TOKEN>
<TOKEN id="token-15-32" pos="word" morph="none" start_char="2716" end_char="2723">Medicina</TOKEN>
<TOKEN id="token-15-33" pos="word" morph="none" start_char="2725" end_char="2726">de</TOKEN>
<TOKEN id="token-15-34" pos="word" morph="none" start_char="2728" end_char="2738">Laboratorio</TOKEN>
<TOKEN id="token-15-35" pos="word" morph="none" start_char="2740" end_char="2742">del</TOKEN>
<TOKEN id="token-15-36" pos="word" morph="none" start_char="2744" end_char="2753">Karolinska</TOKEN>
<TOKEN id="token-15-37" pos="word" morph="none" start_char="2755" end_char="2764">Institutet</TOKEN>
<TOKEN id="token-15-38" pos="word" morph="none" start_char="2766" end_char="2766">y</TOKEN>
<TOKEN id="token-15-39" pos="word" morph="none" start_char="2768" end_char="2774">coautor</TOKEN>
<TOKEN id="token-15-40" pos="word" morph="none" start_char="2776" end_char="2778">del</TOKEN>
<TOKEN id="token-15-41" pos="word" morph="none" start_char="2780" end_char="2786">estudio</TOKEN>
<TOKEN id="token-15-42" pos="punct" morph="none" start_char="2787" end_char="2787">.</TOKEN>
</SEG>
<SEG id="segment-16" start_char="2790" end_char="2814">
<ORIGINAL_TEXT>Medicamento bien tolerado</ORIGINAL_TEXT>
<TOKEN id="token-16-0" pos="word" morph="none" start_char="2790" end_char="2800">Medicamento</TOKEN>
<TOKEN id="token-16-1" pos="word" morph="none" start_char="2802" end_char="2805">bien</TOKEN>
<TOKEN id="token-16-2" pos="word" morph="none" start_char="2807" end_char="2814">tolerado</TOKEN>
</SEG>
<SEG id="segment-17" start_char="2818" end_char="2997">
<ORIGINAL_TEXT>Los pacientes, que tenían una edad media de 81 años, toleraron bien el fármaco con una reducción de la inflamación desde los primeros días de tratamiento, según los investigadores.</ORIGINAL_TEXT>
<TOKEN id="token-17-0" pos="word" morph="none" start_char="2818" end_char="2820">Los</TOKEN>
<TOKEN id="token-17-1" pos="word" morph="none" start_char="2822" end_char="2830">pacientes</TOKEN>
<TOKEN id="token-17-2" pos="punct" morph="none" start_char="2831" end_char="2831">,</TOKEN>
<TOKEN id="token-17-3" pos="word" morph="none" start_char="2833" end_char="2835">que</TOKEN>
<TOKEN id="token-17-4" pos="word" morph="none" start_char="2837" end_char="2842">tenían</TOKEN>
<TOKEN id="token-17-5" pos="word" morph="none" start_char="2844" end_char="2846">una</TOKEN>
<TOKEN id="token-17-6" pos="word" morph="none" start_char="2848" end_char="2851">edad</TOKEN>
<TOKEN id="token-17-7" pos="word" morph="none" start_char="2853" end_char="2857">media</TOKEN>
<TOKEN id="token-17-8" pos="word" morph="none" start_char="2859" end_char="2860">de</TOKEN>
<TOKEN id="token-17-9" pos="word" morph="none" start_char="2862" end_char="2863">81</TOKEN>
<TOKEN id="token-17-10" pos="word" morph="none" start_char="2865" end_char="2868">años</TOKEN>
<TOKEN id="token-17-11" pos="punct" morph="none" start_char="2869" end_char="2869">,</TOKEN>
<TOKEN id="token-17-12" pos="word" morph="none" start_char="2871" end_char="2879">toleraron</TOKEN>
<TOKEN id="token-17-13" pos="word" morph="none" start_char="2881" end_char="2884">bien</TOKEN>
<TOKEN id="token-17-14" pos="word" morph="none" start_char="2886" end_char="2887">el</TOKEN>
<TOKEN id="token-17-15" pos="word" morph="none" start_char="2889" end_char="2895">fármaco</TOKEN>
<TOKEN id="token-17-16" pos="word" morph="none" start_char="2897" end_char="2899">con</TOKEN>
<TOKEN id="token-17-17" pos="word" morph="none" start_char="2901" end_char="2903">una</TOKEN>
<TOKEN id="token-17-18" pos="word" morph="none" start_char="2905" end_char="2913">reducción</TOKEN>
<TOKEN id="token-17-19" pos="word" morph="none" start_char="2915" end_char="2916">de</TOKEN>
<TOKEN id="token-17-20" pos="word" morph="none" start_char="2918" end_char="2919">la</TOKEN>
<TOKEN id="token-17-21" pos="word" morph="none" start_char="2921" end_char="2931">inflamación</TOKEN>
<TOKEN id="token-17-22" pos="word" morph="none" start_char="2933" end_char="2937">desde</TOKEN>
<TOKEN id="token-17-23" pos="word" morph="none" start_char="2939" end_char="2941">los</TOKEN>
<TOKEN id="token-17-24" pos="word" morph="none" start_char="2943" end_char="2950">primeros</TOKEN>
<TOKEN id="token-17-25" pos="word" morph="none" start_char="2952" end_char="2955">días</TOKEN>
<TOKEN id="token-17-26" pos="word" morph="none" start_char="2957" end_char="2958">de</TOKEN>
<TOKEN id="token-17-27" pos="word" morph="none" start_char="2960" end_char="2970">tratamiento</TOKEN>
<TOKEN id="token-17-28" pos="punct" morph="none" start_char="2971" end_char="2971">,</TOKEN>
<TOKEN id="token-17-29" pos="word" morph="none" start_char="2973" end_char="2977">según</TOKEN>
<TOKEN id="token-17-30" pos="word" morph="none" start_char="2979" end_char="2981">los</TOKEN>
<TOKEN id="token-17-31" pos="word" morph="none" start_char="2983" end_char="2996">investigadores</TOKEN>
<TOKEN id="token-17-32" pos="punct" morph="none" start_char="2997" end_char="2997">.</TOKEN>
</SEG>
<SEG id="segment-18" start_char="2999" end_char="3241">
<ORIGINAL_TEXT>Los efectos secundarios del uso prolongado de baricitinib informados anteriormente, incluidas la coagulopatía y la trombosis, no fueron evidentes en ninguno de los pacientes, posiblemente debido al tratamiento con medicamentos anticoagulantes.</ORIGINAL_TEXT>
<TOKEN id="token-18-0" pos="word" morph="none" start_char="2999" end_char="3001">Los</TOKEN>
<TOKEN id="token-18-1" pos="word" morph="none" start_char="3003" end_char="3009">efectos</TOKEN>
<TOKEN id="token-18-2" pos="word" morph="none" start_char="3011" end_char="3021">secundarios</TOKEN>
<TOKEN id="token-18-3" pos="word" morph="none" start_char="3023" end_char="3025">del</TOKEN>
<TOKEN id="token-18-4" pos="word" morph="none" start_char="3027" end_char="3029">uso</TOKEN>
<TOKEN id="token-18-5" pos="word" morph="none" start_char="3031" end_char="3040">prolongado</TOKEN>
<TOKEN id="token-18-6" pos="word" morph="none" start_char="3042" end_char="3043">de</TOKEN>
<TOKEN id="token-18-7" pos="word" morph="none" start_char="3045" end_char="3055">baricitinib</TOKEN>
<TOKEN id="token-18-8" pos="word" morph="none" start_char="3057" end_char="3066">informados</TOKEN>
<TOKEN id="token-18-9" pos="word" morph="none" start_char="3068" end_char="3080">anteriormente</TOKEN>
<TOKEN id="token-18-10" pos="punct" morph="none" start_char="3081" end_char="3081">,</TOKEN>
<TOKEN id="token-18-11" pos="word" morph="none" start_char="3083" end_char="3091">incluidas</TOKEN>
<TOKEN id="token-18-12" pos="word" morph="none" start_char="3093" end_char="3094">la</TOKEN>
<TOKEN id="token-18-13" pos="word" morph="none" start_char="3096" end_char="3107">coagulopatía</TOKEN>
<TOKEN id="token-18-14" pos="word" morph="none" start_char="3109" end_char="3109">y</TOKEN>
<TOKEN id="token-18-15" pos="word" morph="none" start_char="3111" end_char="3112">la</TOKEN>
<TOKEN id="token-18-16" pos="word" morph="none" start_char="3114" end_char="3122">trombosis</TOKEN>
<TOKEN id="token-18-17" pos="punct" morph="none" start_char="3123" end_char="3123">,</TOKEN>
<TOKEN id="token-18-18" pos="word" morph="none" start_char="3125" end_char="3126">no</TOKEN>
<TOKEN id="token-18-19" pos="word" morph="none" start_char="3128" end_char="3133">fueron</TOKEN>
<TOKEN id="token-18-20" pos="word" morph="none" start_char="3135" end_char="3143">evidentes</TOKEN>
<TOKEN id="token-18-21" pos="word" morph="none" start_char="3145" end_char="3146">en</TOKEN>
<TOKEN id="token-18-22" pos="word" morph="none" start_char="3148" end_char="3154">ninguno</TOKEN>
<TOKEN id="token-18-23" pos="word" morph="none" start_char="3156" end_char="3157">de</TOKEN>
<TOKEN id="token-18-24" pos="word" morph="none" start_char="3159" end_char="3161">los</TOKEN>
<TOKEN id="token-18-25" pos="word" morph="none" start_char="3163" end_char="3171">pacientes</TOKEN>
<TOKEN id="token-18-26" pos="punct" morph="none" start_char="3172" end_char="3172">,</TOKEN>
<TOKEN id="token-18-27" pos="word" morph="none" start_char="3174" end_char="3185">posiblemente</TOKEN>
<TOKEN id="token-18-28" pos="word" morph="none" start_char="3187" end_char="3192">debido</TOKEN>
<TOKEN id="token-18-29" pos="word" morph="none" start_char="3194" end_char="3195">al</TOKEN>
<TOKEN id="token-18-30" pos="word" morph="none" start_char="3197" end_char="3207">tratamiento</TOKEN>
<TOKEN id="token-18-31" pos="word" morph="none" start_char="3209" end_char="3211">con</TOKEN>
<TOKEN id="token-18-32" pos="word" morph="none" start_char="3213" end_char="3224">medicamentos</TOKEN>
<TOKEN id="token-18-33" pos="word" morph="none" start_char="3226" end_char="3240">anticoagulantes</TOKEN>
<TOKEN id="token-18-34" pos="punct" morph="none" start_char="3241" end_char="3241">.</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>
